Atlantic Fish, an emerging Raleigh company developing cultivated seafood, has received a $50,000 SEED grant from North ...

Our state is home to a broad range of natural resources and scientific knowledge that, when combined, can transform communities from Manteo to Murphy. To bring that vision to reality, we opened our ...

The post-award management of NCBiotech grants and loans is administered NCBiotech's Contracts and Grants Department. If you have questions related to budget changes, project extensions, reporting or ...

North Carolina is a global leader in gene therapy thanks to its renowned life science workforce development programs and the scientific output of its research universities. For example, Pfizer’s first ...

In this technical session, Creative Biolabs has invited Dr. Leyton to describe the need to develop a more precise method in investigating nuclear transport dynamics of NLS-therapeutics. Moreover, Dr.

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

Cell Microsystems, a provider of tools and solutions for sorting and isolating single cells, has been awarded a $1.5 million federal grant to develop a system for imaging thousands of single cells and ...

Merakris Therapeutics, LLC, a Research Triangle Park regenerative medicine company developing wound-healing products for skin and eyes, has launched a new skin-graft alternative to help protect and ...

In 1984, three of North Carolina’s largest traditional industries – tobacco, textiles and furniture – were declining as they were offshored to countries with cheaper labor. The state needed a new ...

The precision health ecosystem in North Carolina is strong and diverse. With deep expertise in big data and bioinformatics, North Carolina is leading the way for more personalized health and health ...

Greater Charlotte is home to a robust, expanding life sciences cluster with a plethora of international firms. Assets in the region span medtech/medical device development and manufacturing, ...

Norris Tolson, President and CEO of the North Carolina Biotechnology Center, today announced that he will be stepping down, effective June 30. The NCBiotech Board of Directors will begin a search for ...